PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
Ovintiv Inc. (OVV)
40.910.33 (-0.80%)
40.40 - 41.05
29.80 - 47.18
2.12M / 3.66M (Avg.)
18.02 | 2.27
Shows the trajectory of a company's cash-generation capacity. Consistent growth in operating and free cash flow suggests a robust, self-funding business model—crucial for value investors seeking undervalued, cash-rich opportunities.
-55.65%
Both yoy net incomes decline, with CRK at -68.28%. Martin Whitman would view it as a broader sector or cyclical slump hitting profits.
2.44%
Less D&A growth vs. CRK's 421.37%, reducing the hit to reported earnings. David Dodd would confirm that core assets remain sufficient.
-72.15%
Both lines show negative yoy. Martin Whitman would see an industry or cyclical factor reducing tax deferrals for both players.
105.88%
SBC growth well above CRK's 74.64%. Michael Burry would flag major dilution risk vs. competitor’s approach.
-172.73%
Both reduce yoy usage, with CRK at -68.12%. Martin Whitman would find an industry or cyclical factor prompting leaner operational approaches.
207.02%
AR growth well above CRK's 178.06%. Michael Burry would fear inflated sales or less stringent credit controls vs. competitor.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
-172.73%
Both reduce yoy usage, with CRK at -172.13%. Martin Whitman would suspect an industry or cyclical factor pulling back on these items.
29.17%
Some yoy increase while CRK is negative at -20.03%. John Neff would see competitor possibly reining in intangible charges or revaluations more effectively than we do.
-16.56%
Negative yoy CFO while CRK is 11.67%. Joel Greenblatt would see a disadvantage in operational cash generation vs. competitor.
24.53%
Some CapEx rise while CRK is negative at -58.06%. John Neff would see competitor possibly building capacity while we hold back expansions.
1073.33%
Acquisition growth of 1073.33% while CRK is zero at 0.00%. Bruce Berkowitz sees a mild outflow that must deliver synergy to justify the difference.
-373.33%
Negative yoy purchasing while CRK stands at 0.00%. Joel Greenblatt sees a near-term liquidity advantage unless competitor’s new investments produce outsized returns.
No Data
No Data available this quarter, please select a different quarter.
-373.33%
Both yoy lines negative, with CRK at -34020.03%. Martin Whitman suspects a cyclical or strategic rationale for cutting extra invests in the niche.
29.31%
We have mild expansions while CRK is negative at -919.21%. John Neff sees competitor possibly divesting or pausing expansions more aggressively.
91.75%
We repay more while CRK is negative at -868.93%. John Neff notes advantage in lowering leverage if competitor is ramping up debt or repaying less.
No Data
No Data available this quarter, please select a different quarter.
66.56%
Buyback growth of 66.56% while CRK is zero at 0.00%. Bruce Berkowitz sees a modest per-share advantage that might accumulate if the stock is below intrinsic value.